Drug news
Naloxegol filed with the FDA for Opioid Constipation
AstraZeneca has filed a new drug submission with the FDA for Naloxegol (naxolol), for the treatment of Opioid induced Constipation. This follows filings in the EU and in Canada during August.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
1 mins